Geisinger Wyoming Valley Medical Center
1000 E Mountain Blvd
Wilkes-Barre, Pennsylvania 18711
(570) 808-7300 http://www.geisinger.org

Use our guide to learn which trials are right for you!

Over the last decade, Geisinger Wyoming Valley has nearly doubled in size, and its innovative programs have helped Geisinger Health System earn numerous national accolades.

Compassionate professionals - including some of the region's most highly trained specialists - and advanced technology make Geisinger Wyoming Valley a destination for those with the most complex medical concerns.

We've found
28 trials
at this facility
Oncology Clinical Trial
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 11/5/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Status: Enrolling, Phase III
Updated: 11/7/2014
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 12/6/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 4/16/2014
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer
Status: Enrolling, Phase II
Updated: 4/9/2015
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Lymphoma Clinical Trial
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 3/13/2015
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
Status: Enrolling
Updated: 9/11/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 8/14/2012
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Status: Enrolling
Updated: 11/18/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
Status: Enrolling, Phase II
Updated: 12/2/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/18/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
Status: Enrolling, Phase II
Updated: 11/7/2014
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Status: Enrolling, Phase II
Updated: 10/7/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Status: Enrolling, Phase III
Updated: 1/15/2014
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
Status: Enrolling
Updated: 8/1/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
Status: Enrolling, Phase II
Updated: 8/18/2015
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 9/9/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
Status: Enrolling, Phase III
Updated: 12/6/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Status: Enrolling, Phase III
Updated: 12/6/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 1/14/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Status: Enrolling, Phase II
Updated: 12/6/2013
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Ductal Breast Carcinoma in Situ Clinical Trial
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Status: Enrolling, Phase III
Updated: 11/7/2014
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Status: Enrolling
Updated: 11/19/2012
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Clinical Trial
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Status: Enrolling, Phase III
Updated: 1/28/2016
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma Clinical Trial
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Status: Enrolling, Phase II
Updated: 3/4/2016
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials